share_log

CVS Health | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

CVS Health | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

西維斯健康 | S-8：員工福利計劃證券登記
美股sec公告 ·  05/24 04:40
牛牛AI助理已提取核心訊息
On May 22, 2024, CVS Health Corporation filed a Registration Statement on Form S-8 with the Securities and Exchange Commission (SEC) to register an additional 33,500,000 shares of common stock for its 2017 Incentive Compensation Plan. This filing is in accordance with General Instruction E to Form S-8 and follows previous registrations of shares for the same plan in 2017 and 2020. The newly registered shares are intended for sale to participants under the plan, which aims to incentivize and retain key employees by allowing them to acquire a proprietary interest in the company. The Registration Statement incorporates by reference the company's previous filings, including its Annual Report for the fiscal year ended December 31, 2023, and its Quarterly Report for the period ended March 31, 2024. The Plan includes provisions for various types of awards, including options, stock appreciation rights, and restricted stock, with specific clauses addressing the effects of a Change in Control on award vesting.
On May 22, 2024, CVS Health Corporation filed a Registration Statement on Form S-8 with the Securities and Exchange Commission (SEC) to register an additional 33,500,000 shares of common stock for its 2017 Incentive Compensation Plan. This filing is in accordance with General Instruction E to Form S-8 and follows previous registrations of shares for the same plan in 2017 and 2020. The newly registered shares are intended for sale to participants under the plan, which aims to incentivize and retain key employees by allowing them to acquire a proprietary interest in the company. The Registration Statement incorporates by reference the company's previous filings, including its Annual Report for the fiscal year ended December 31, 2023, and its Quarterly Report for the period ended March 31, 2024. The Plan includes provisions for various types of awards, including options, stock appreciation rights, and restricted stock, with specific clauses addressing the effects of a Change in Control on award vesting.
2024年5月22日，CVS Health Corporation向美國證券交易委員會（SEC）提交了S-8表格的註冊聲明，要求爲其2017年激勵性薪酬計劃再註冊33,500,000股普通股。該申報符合S-8表格E的一般指令，並遵循了先前在2017年和2020年爲同一計劃註冊的股份。根據該計劃，新註冊的股票將出售給參與者，該計劃旨在通過允許關鍵員工收購公司的專有權益來激勵和留住他們。註冊聲明以引用方式納入了公司先前提交的文件，包括截至2023年12月31日的財政年度的年度報告和截至2024年3月31日的季度報告。該計劃包括各種獎勵的條款，包括期權、股票增值權和限制性股票，並有具體條款涉及控制權變更對獎勵歸屬的影響。
2024年5月22日，CVS Health Corporation向美國證券交易委員會（SEC）提交了S-8表格的註冊聲明，要求爲其2017年激勵性薪酬計劃再註冊33,500,000股普通股。該申報符合S-8表格E的一般指令，並遵循了先前在2017年和2020年爲同一計劃註冊的股份。根據該計劃，新註冊的股票將出售給參與者，該計劃旨在通過允許關鍵員工收購公司的專有權益來激勵和留住他們。註冊聲明以引用方式納入了公司先前提交的文件，包括截至2023年12月31日的財政年度的年度報告和截至2024年3月31日的季度報告。該計劃包括各種獎勵的條款，包括期權、股票增值權和限制性股票，並有具體條款涉及控制權變更對獎勵歸屬的影響。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

獨立文件2  查看翻譯

獨立文件3  查看翻譯

獨立文件4  查看翻譯

獨立文件5  查看翻譯

獨立文件6  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。